Picture of IRADIMED logo

IRMD — IRADIMED News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

IRadimed Corp expected to post earnings of 39 cents a share - Earnings Preview

* IRadimed Corp  IRMD.OQ   IRMD.O  is expected to show a
rise in
quarterly revenue when it reports  results on October 31 for the
period ending September 30 2024
    * The Winter Springs Florida-based  company is expected to
report
a 9.6% increase in revenue to $18.098 million from $16.51
million a year ago, according to the mean estimate from 2
analysts, based on LSEG data.The company's guidance on August 1
2024, for the period ended September 30, was for revenue between
$18.00 million and $18.20 million.
    * ​LSEG's mean analyst estimate for IRadimed Corp is for
earnings
of 39 cents per share. The company's EPS guidance on August 1
2024, for the period ended September 30, was between $0.38 and
$0.41 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for IRadimed
Corp is
$60.00​, above​ its last closing price of $52.03. ​​​

This summary was machine generated October 29 at 13:48 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on IRADIMED

See all news